**Question:** Treatment of vernal keratoconjunctivitis includes ail except -

A. Topical steroids
B. Topical antibiotics
C. Topical antihistamines
D. Topical cyclosporine

**Core Concept:** Vernal keratoconjunctivitis (VKC) is a type of allergic conjunctivitis that primarily affects children and young adults. It is characterized by inflammation of the cornea and conjunctiva, resulting in symptoms like itching, burning, and redness. Treatment aims to alleviate these symptoms and reduce inflammation.

**Why the Correct Answer is Right:** Topical steroids (Option A) are a common treatment for ocular inflammation, but they are contraindicated in VKC due to their immunosuppressive effects, which might increase the risk of infection and worsen the allergic response.

**Why Each Wrong Option is Incorrect:**

**Option B (Topical Antibiotics):** Antibiotics are not indicated in VKC as the condition is primarily an allergic reaction and not a bacterial infection. Using antibiotics would not address the underlying cause of inflammation and could potentially mask the true nature of the condition.

**Option C (Topical Antihistamines):** Anti-histamines are primarily used to treat allergic reactions and reduce symptoms like itching. However, in VKC, the allergic response is already present, and antihistamines would not address the primary cause of inflammation.

**Option D (Topical Cyclosporine):** Topical cyclosporine (CsA) is a calcineurin inhibitor used to suppress the immune response and reduce ocular inflammation. Since VKC involves an allergic response, using topical cyclosporine would target the primary cause and help manage the inflammation effectively.

**Clinical Pearl:** The correct treatment for VKC involves addressing the underlying immunological response and inflammation, as well as managing symptoms. In this case, topical cyclosporine (Option D) is the appropriate choice, while avoiding topical steroids, antibiotics, and antihistamines.

**Correct Answer:** D. Topical cyclosporine

---

**Why the Correct Answer is Right:** Vernal keratoconjunctivitis is an allergic disorder involving the immune system, specifically the Th2-mediated immune response. Topical cyclosporine (CsA) is a calcineurin inhibitor that suppresses the T-cell activation and production of pro-inflammatory cytokines, thereby reducing ocular inflammation and alleviating symptoms in VKC. This targeted approach is more effective than using broad-spectrum treatments like steroids, antibiotics, and antihistamines, which do not address the primary immune response in VKC.

**Why Each Wrong Option is Incorrect:**

**Option A (Topical Steroids):** Steroids are immunosuppressive agents that inhibit the release of pro-inflammatory cytokines, thereby reducing inflammation and alleviating symptoms. However, in VKC, the primary cause of ocular inflammation is the Th2-mediated immune response, which steroids do not address. Instead, they might